Marble Wealth LLC Purchases Shares of 11,109 Cardinal Health, Inc. $CAH

Marble Wealth LLC purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 11,109 shares of the company’s stock, valued at approximately $2,283,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Kesler Norman & Wride LLC acquired a new position in Cardinal Health in the fourth quarter valued at approximately $1,007,000. Calton & Associates Inc. bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $252,000. Natixis Advisors LLC increased its holdings in shares of Cardinal Health by 19.6% during the fourth quarter. Natixis Advisors LLC now owns 521,251 shares of the company’s stock valued at $107,117,000 after acquiring an additional 85,590 shares in the last quarter. Beaton Management Co. Inc. bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $225,000. Finally, Crestmont Private Wealth LLC bought a new stake in shares of Cardinal Health during the fourth quarter valued at approximately $264,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.1%

Shares of NYSE:CAH opened at $194.96 on Wednesday. The stock has a market cap of $45.66 billion, a PE ratio of 29.81, a price-to-earnings-growth ratio of 1.16 and a beta of 0.52. The stock’s fifty day simple moving average is $203.21 and its two-hundred day simple moving average is $208.75. Cardinal Health, Inc. has a 1-year low of $137.75 and a 1-year high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a yield of 1.1%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is presently 31.19%.

Analyst Ratings Changes

CAH has been the subject of several recent research reports. TD Cowen boosted their price objective on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a report on Friday, May 1st. Wells Fargo & Company decreased their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. JPMorgan Chase & Co. decreased their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Finally, Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $241.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.